Simparica For Dogs 88.1-132 lbs (40.1-60 kg)

Simparica For Dogs 88.1-132 lbs (40.1-60 kg)

Simparica for Dogs 88.1-132 lbs (40.1-60 kg) is a chewable tablet designed to provide comprehensive protection against fleas and ticks. This fast-acting treatment kills adult fleas before they can lay eggs and eliminates various tick species, including the lone star tick, Gulf Coast tick, American dog tick, and brown dog tick. Formulated with the active ingredient Sarolaner, Simparica offers a full month of continuous protection, ensuring your large dog remains free from the discomfort and health risks associated with flea and tick infestations. The tasty chewable tablet is easy to administer and well-accepted by dogs.

Indications

Simparica for Dogs 88.1-132 lbs (40.1-60 kg) is indicated for the treatment and prevention of flea infestations (Ctenocephalides felis) and the treatment and control of tick infestations. It is effective against various tick species, including black-legged ticks (Ixodes scapularis), Gulf Coast ticks (Amblyomma maculatum), American dog ticks (Dermacentor variabilis), and brown dog ticks (Rhipicephalus sanguineus). Simparica is suitable for dogs 6 months of age and older, weighing 88.1-132 lbs (40.1-60 kg).

Possible Side Effects

The most commonly reported side effects of Simparica include vomiting, diarrhea, lethargy, anorexia, and excessive drooling. In rare cases, neurological signs such as tremors, ataxia, and seizures have been reported in dogs taking isoxazoline class drugs, including Sarolaner. Use Simparica with caution in dogs with a history of seizures or neurological disorders.

Precautions

Sarolaner, the active ingredient in Simparica, belongs to the isoxazoline class, which has been associated with neurologic adverse reactions such as tremors, ataxia, and seizures. Seizures have been reported in dogs taking isoxazoline drugs, even in those without a prior history of seizures. Therefore, use Simparica with caution in dogs with a history of seizures or neurological disorders. Simparica has not been proven effective for puppies less than 6 months of age.

Simparica Protective Measures

• Not for Human Consumption: Simparica is intended for use in dogs only.
• Use with Caution: Use Simparica with caution in dogs with a history of seizures or neurological disorders, as Sarolaner has been associated with neurologic adverse reactions such as tremors, ataxia, and seizures.
• Consult Your Vet: Consult your veterinarian before using Simparica in breeding, pregnant, or lactating females.
• Storage and Handling: Keep the chewable tablet out of reach of pets and children. Do not open the package until required. Avoid eating, drinking, and smoking while administering the dosage. Wash hands with soap and water after handling the chewable.

Contraindications

Simparica is contraindicated for use in dogs with known hypersensitivity to Sarolaner or any of the product’s components. Do not use Simparica in dogs that have shown adverse reactions to isoxazoline class drugs. Simparica is also contraindicated in puppies less than 6 months of age.